Previous Close | 6.80 |
Open | 6.80 |
Bid | 6.50 |
Ask | 9.20 |
Strike | 90.00 |
Expire Date | 2024-09-20 |
Day's Range | 6.80 - 6.80 |
Contract Range | N/A |
Volume | |
Open Interest | 28 |
On May 29, 2024, Stewart Strong, President of Global Hospital at Haemonetics Corp (NYSE:HAE), sold 8,857 shares of the company.
On May 29, 2024, Michelle Basil, Executive Vice President and General Counsel of Haemonetics Corp (NYSE:HAE), executed a sale of 12,990 shares of the company at a price of $88.08 per share.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.